Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.

Inflamm Bowel Dis

*Division of Gastroenterology, Hôpital Neuchâtelois, Neuchâtel, Switzerland;†Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;‡Division of Gastroenterology Clinic for Visceral Surgery and Medicine, Inselspital Bern, Bern, Switzerland;§Division of Gastroenterology and Hepxatology, Saint-Antoine Hospital, Pierre et Marie Curie-Paris 6 University, Paris, France;‖Division of Gastroenterology, University Hospital of Basel, Basel, Switzerland;¶Division of Gastroenterology and Hepatology, Ospedale Regionale di Lugano, Lugano, Switzerland;**Division of Gastroenterology and Hepatology, Lindenhofspital Bern, Bern, Switzerland;††Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland;‡‡Division of Gastroenterology and Hepatology, Stadtspital Triemli, Zurich, Switzerland; and§§Crohn and Colitis Centre, Clinique La Source-Beaulieu, Lausanne, Switzerland.

Published: November 2016

The relevance of azathioprine and 6-mercaptopurine therapy in inflammatory bowel disease, Crohn's disease, and ulcerative colitis, has been challenged in recent publications. In this article, a panel of experts gives advice, based on the relevant literature, on indications and practical use of azathioprine/6-mercaptopurine, prevention, and management of drug adverse reactions and special situations such as vaccination, pregnancy, and lactation.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000923DOI Listing

Publication Analysis

Top Keywords

azathioprine 6-mercaptopurine
8
inflammatory bowel
8
bowel disease
8
experts opinion
4
opinion practical
4
practical azathioprine
4
6-mercaptopurine inflammatory
4
disease relevance
4
relevance azathioprine
4
6-mercaptopurine therapy
4

Similar Publications

Background: Ulcerative colitis (UC) is a chronic inflammatory condition requiring continuous treatment and monitoring. There is limited pharmacokinetic data on vedolizumab during maintenance therapy and the effect of thiopurines on vedolizumab trough concentrations is unknown.

Aim: To investigate the exposure-response relationship of vedolizumab and the impact of thiopurine withdrawal in UC patients who have achieved sustained clinical and endoscopic remission during maintenance therapy.

View Article and Find Full Text PDF

Background: Thiopurine methyltransferase (TPMT) plays a crucial role in the detoxification of thiopurine drugs, including the antimetabolites azathioprine and 6-mercaptopurine (6-MP) used to treat autoimmune diseases and various cancers. These drugs interfere with DNA synthesis by inhibiting the production of purine-containing nucleotides, leading to the death of rapidly dividing cells. TPMT inactivates thiopurine drugs by methylating at the thiol group.

View Article and Find Full Text PDF

Introduction: the purpose of our study is to evaluate the efficacy of azathioprine as first-line treatment in patients with relapsing-remitting multiple sclerosis (RRMS) or progressive multiple sclerosis (PMS), who were supposed to be treated with beta-interferons but, due to limited resources, received azathioprine instead.

Method: among the 31 patients, 17 had relapsing-remitting MS (RRMS), 11 had primary progressive MS (PPMS), and 3 had secondary progressive MS (SPMS). Patients received azathioprine orally at a dose of 3 mg/kg/day over 2 years.

View Article and Find Full Text PDF

Efficacy and safety of azathioprine in patients with Cronkhite-Canada syndrome: a case series from Peking Union Medical College Hospital.

BMC Pharmacol Toxicol

December 2024

Department of Gastroenterology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.

Background: Cronkhite-Canada syndrome (CCS) is a rare non-hereditary chronic inflammatory disease characteristic of gastrointestinal polyps and ectodermal abnormalities. Corticosteroid therapy is the mainstay medication for CCS. Few studies indicated immunosuppressants might be the choices for patients with steroid refractory, steroid dependent or intolerant.

View Article and Find Full Text PDF

Behçet's disease is a clinical diagnosis with variable presentations. Liver involvement is rare in the absence of vascular complications. We describe a patient diagnosed with Hashimoto's thyroiditis and autoimmune hepatitis on azathioprine who developed extensive aphthous ulcers approximately 10 years later.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!